Background: Although several studies assessed the effect of bisphosphonate (BIS) administration on alveolar bone loss, this relationship has not been fully investigated using longitudinal analysis.

Results of this study indicate that, after 2 years of follow up, the oral administration of BIS did not have a protective effect on the mean alveolar bone loss. Although a recent systematic review ...

Activation of the immune system in some pathological conditions ... net effect of IFN-γ in three mouse models of pathological bone loss—lipopolysaccharide injection (which mimics bacterial ...

Aguirre-Ghiso and colleagues determined that when breast cancer DCCs spread to the lung's air sacs (alveoli), they are kept in a dormant state by immune cells known as alveolar macrophages.